REQUEST A DEMO
Total
USD $0.00
Search more companies

LAVET Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: LAVET Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

lavet pharmaceuticals ltd is a Hungarian company. The company operates in the veterinary medicine industry, focusing on the development, registration, and manufacture of veterinary medicinal products. lavet pharmaceuticals ltd aims to provide pharmaceutical products for both national and international veterinary markets. Their solutions are dedicated to preserving animal health and vitality.

Headquarters
Batthyany utca 6.
Kistarcsa; Pest; Postal Code: 2143

Contact Details: Purchase the LAVET Kft. report to view the information.

Website: http://www.lavet.hu

Basic Information
Total Employees:
Purchase the LAVET Kft. report to view the information.
Registered Capital:
Purchase the LAVET Kft. report to view the information.
Financial Auditors:
Purchase the LAVET Kft. report to view the information.
Incorporation Date:
December 05, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Zylavet Kft
Company Performance
Financial values in the chart are available after LAVET Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.06%
Total operating revenue
5.99%
Operating profit (EBIT)
21.46%
EBITDA
20.81%
Net Profit (Loss) for the Period
76.84%
Total assets
9.19%
Total equity
11.36%
Operating Profit Margin (ROS)
2.64%
Net Profit Margin
11.07%
Return on Equity (ROE)
5.12%
Quick Ratio
3.04%
Cash Ratio
2.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?